162
Views
1
CrossRef citations to date
0
Altmetric
Major Articles

Pain-related disability and opioid use in a sample of young adults with current pain: The explanatory role of distress tolerance

, MD, PhDORCID Icon, & ORCID Icon
Pages 1206-1212 | Received 06 Sep 2020, Accepted 15 Jan 2021, Published online: 25 Oct 2021

Reference

  • Wilson S. Chronic pain in young adults. Pain Rehabil. 2017;2017(43):5–7.
  • Mallen C, Peat G, Thomas E, Croft P. Severely disabling chronic pain in young adults: prevalence from a population-based postal survey in North Staffordshire. BMC Musculoskelet Disord. 2005;6(1):42.
  • Centers for Disease Control and Prevention (CDC). Today’s Heroin Epidemic: Vital Signs. Atlanta: CDC; 2015.
  • Tompkins DA, Hobelmann JG, Compton P. Providing chronic pain management in the “Fifth Vital Sign” Era: Historical and treatment perspectives on a modern-day medical dilemma. Drug Alcohol Depend. 2017;173:S11–S21. doi:10.1016/j.drugalcdep.2016.12.002.
  • Kindler L, DeBar L, Elder C. Primary care based integrated assessment and treatment for patients with complex chronic pain conditions: foundation and development. J Pain. 2014;15(4):S114.
  • National Center for Health Statistics. Health, United States, 2016, with Chartbook on Long-Term Trends in Health. Washington DC: Government Printing Office; 2017.
  • Bonar EE, Coughlin L, Roche JS, et al. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review. Prev Med. 2020;132:105972. doi:10.1016/j.ypmed.2019.105972.
  • Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med. 2015;80:5–9. doi:10.1016/j.ypmed.2015.04.003.
  • White House Council of Economic Advisors. 2017. The Underestimated Cost of the Opioid Crisis.
  • Beyraghi N, Hosseinzadeh M, Hashemi M, Moghaddam Y. Evaluation of the relationship between disability and pain severity with anxiety and depression in chronic low back pain patient: Research and review. Int J Contemp Dent Med Rev. 2016;2016:010816.
  • Garbi MDOSS, Hortense P, Gomez RRF, Silva TDCRD, Castanho ACF, Sousa FAEM. Pain intensity, disability and depression in individuals with chronic back pain. Rev Lat Am Enfermagem. 2014;22(4):569–575.
  • Lentz TA, Rhon DI, George S. Predicting opioid use, increased health care utilization and high costs for musculoskeletal pain: what factors mediate pain intensity and disability?J Pain. 2019;21(1–2):135–145.
  • Lutz J, Gross RT, Vargovich A. Corrigendum to ‘Difficulties in emotion regulation and chronic pain-related disability and opioid misuse’’ Addictive Behaviors 87 (2018) 200-205. Addict Behav 2019;95:200–205.
  • Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6(1):46.
  • Lipari RN, Hughes A. 2013. Nonmedical use of prescription-type drugs, by county type. The CBHSQ Report: Substance Abuse and Mental Health Services Administration (US).
  • Leyro TM, Zvolensky MJ, Bernstein A. Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults. Psychol Bull. 2010;136(4):576. doi:10.1037/a0019712.
  • McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards R. Distress intolerance and prescription opioid misuse among patients with chronic pain. J Pain. 2016;17(7):806–814.
  • McHugh RK, Kneeland ET, Edwards RR, Jamison R, Weiss R. Pain catastrophizing and distress intolerance: prediction of pain and emotional stress reactivity. J Behav Med. 2019;43(4):623–629.
  • Rogers AH, Bakhshaie J, Mayorga NA, et al. Distress tolerance and pain experience among young adults. Psychol Health Med. 2018;23(10):1231–1238.
  • Lampert R, Tuit K, Hong K-I, Donovan T, Lee F, Sinha RJS. Cumulative stress and autonomic dysregulation in a community sample. Stree 2016;19(3):269–279.
  • Trafton JA, Gifford EV. Biological bases of distress tolerance. In: Zvolensky MJ, Bernstein A, Vujanovic AA , eds. Distress Tolerance: Theory, Research, and Clinical Applications. New York: The Guilford Press; 2011:80–102.
  • Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50(2):133–149.
  • Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff B. Introduction of a self-report version of the prescription drug use questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36(4):383–395.
  • Bakhshaie J, Rogers AH, Kauffman BY, et al. Emotion dysregulation as an explanatory factor in the relation between negative affectivity and non-medical use of opioid in a diverse young adult sample. Addict Behav. 2019;95:103–109. doi:10.1016/j.addbeh.2019.02.025.
  • Presley CA, Meilman PW, Lyerla R. Development of the Core Alcohol and Drug Survey: Initial findings and future directions. J Am Coll Health. 1994;42(6):248–255. doi:10.1080/07448481.1994.9936356.
  • Newcombe D, Tanielu-Stowers H, McDermott R, Stephen J, Nosa V. The validation of the alcohol, smoking and substance involvement screening test (ASSIST) amongst pacific people in New Zealand. NZ J Psychol. 2016;45(1):30.
  • Simons JS, Gaher RM. The Distress Tolerance Scale: development and validation of a self-report measure. Motiv Emot. 2005;29(2):83–102. doi:10.1007/s11031-005-7955-3.
  • Watson D, Clark LA. The PANAS-X: Manual for the positive and negative affect schedule-expanded form. Iowa City: The University of Iowa; 1999.
  • Hayes AF. 2016. The PROCESS macro for SPSS and SAS. Available at: http://www.processmacro.org/index.html
  • Preacher KJ, Hayes A. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Instrum Comput. 2004;36(4):717–731. doi:10.3758/BF03206553.
  • Mooney CF, Mooney CL, Mooney CZ, Duval RD, Duvall R. Bootstrapping: A Nonparametric Approach to Statistical Inference. New York: Sage; 1993.
  • MacKinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect: Distribution of the product and resampling methods. Multivariate Behav Res. 2004;39(1):99–128. doi:10.1207/s15327906mbr3901_4.
  • Preacher KJ, Kelley K. Effect size measures for mediation models: quantitative strategies for communicating indirect effects. Psychol Methods. 2011;16(2):93–115. doi:10.1037/a0022658.
  • Asmundson GJ, Katz J. Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art. Depress Anxiety. 2009;26(10):888–901. doi:10.1002/da.20600.
  • Kaiser AJ, Milich R, Lynam DR, Charnigo RJ. Negative urgency, distress tolerance, and substance abuse among college students. Addict Behav. 2012;37(10):1075–1083.
  • Linehan MM, Schmidt H, Dimeff LA, Craft JC, Kanter J, Comtois K. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict. 1999;8(4):279–292.
  • Mennin D. Emotion regulation therapy: An integrative approach to treatment-resistant anxiety disorders. J Contemp Psychother. 2006;36(2):95–105. doi:10.1007/s10879-006-9012-2.
  • McCabe SE, West BT, Teter CJ, Boyd C. Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addict Behav. 2014;39(7):1176–1182. doi:10.1016/j.addbeh.2014.03.008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.